A.-L. Taksin

High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group

A.-L. Taksin, Ollivier Legrand, Emmanuel Raffoux et al. · Leukemia · 2006 · 288 citations

Medicine, Oncology, Pharmacology +10

Lenalidomide with or without erythropoietin in transfusion-dependent erythropoiesis-stimulating agent-refractory lower-risk MDS without 5q deletion

Andréa Toma, Olivier Kosmider, Sylvie Chevret et al. · Leukemia · 2015 · 121 citations · Full text

Medicine, Hematology, Pharmacotherapy +9

Activity of fludarabine in previously treated Waldenström's macroglobulinemia: a report of 71 cases. Groupe Coopératif Macroglobulinémie.

V. Leblond, T Ben-Othman, Éric Deconinck et al. · Journal of Clinical Oncology · 1998 · 88 citations

Medicine, Oncology, Pharmacotherapy +13

Assessment of global longitudinal strain at low-dose anthracycline-based chemotherapy for the prediction of subsequent cardiotoxicity

C. Charbonnel, R. Convers-Domart, Sophie Rigaudeau et al. · Annales de Cardiologie et d Angéiologie · 2016 · 60 citations

Medicine, Cardiology, Oncology +15

Daily practice management of myelodysplastic syndromes in France: data from 907 patients in a one-week cross-sectional study by the Groupe Francophone des Myelodysplasies

Charikleia Kelaïdi, Aspasia Stamatoullas, Odile Beyne‐Rauzy et al. · Haematologica · 2009 · 19 citations · Full text

Medicine, Hematology, Internal Medicine +15